We are live on
!
Find out more
ICP
Ironvine Capital Partners Portfolio holdings
AUM
$910M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+11.96%
1 Year Est. Return
+10.64%
3 Year Est. Return
+51.78%
5 Year Est. Return
+63.74%
10 Year Est. Return
–
AUM
$801M
AUM Growth
+$2.52M
(+0.32%)
Cap. Flow
-$78.9M
Cap. Flow
% of AUM
-9.85%
Top 10 Holdings %
Top 10 Hldgs %
49.68%
Holding
70
New
–
Increased
–
Reduced
40
Closed
10
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$4.53M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$3.96M |
| 3 |
Lowe's Companies
LOW
|
+$3.83M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
+$3.51M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$3.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.96% |
| 2 | Communication Services | 23.41% |
| 3 | Technology | 16.42% |
| 4 | Healthcare | 12.54% |
| 5 | Consumer Staples | 7.11% |
Similar funds
NAM
PAMI
KCM
BDP
GC
SAA
SDJVC
SDWMA
Ironvine Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Ironvine Capital Partners held 70 positions worth $801M, up 0.32% from $798M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Ironvine Capital Partners withdrew a net $78.9M in Q4 2020, closing 10 positions and reducing 40 holdings. Its most notable exit was HCA Healthcare, an estimated $337K position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 29% a quarter earlier, followed by Communication Services and Technology.
- Ironvine Capital Partners's biggest Q4 2020 reduction was Microsoft, cutting an estimated $4.53M.
- Ironvine Capital Partners fully exited HCA Healthcare in Q4 2020, selling an estimated $337K.
- Ironvine Capital Partners's ten largest holdings make up 50% of its $801M portfolio in Q4 2020.
- Ironvine Capital Partners opened 0 new positions and closed 10 in Q4 2020.
- Ironvine Capital Partners's portfolio value rose 0.32% quarter-over-quarter to $801M.
Based on Ironvine Capital Partners's 13F filing for Q4 2020, filed 2 Feb 2021.